Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantum Magnetics was a pioneer in the development of advanced magnetic sensing systems based on Superconducting Quantum Interference Device (SQUID) technology. While widely known for security applications like explosive detection, the company significantly impacted the healthcare sector through its biomagnetic imaging systems. Their most notable medical contribution was the development of the Ferritometer, a non-invasive device used to measure liver iron concentration in patients with iron overload disorders. This technology offered a painless and accurate alternative to traditional liver biopsies for patients with thalassemia and hemochromatosis. The company was acquired by InVision Technologies in 2003, which was subsequently acquired by GE in 2004. Its innovations laid the groundwork for modern high-sensitivity magnetic diagnostics in clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quantum Magnetics.